Sobi
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Sweden · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Tomtebodavägen 23a, Stockholm, Stockholm...Phone Number
+46 86972000Website
www.sobi.comRevenue
$3 BillionStock Symbol
SOBIIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sobi
Sobi, founded in 2010 and based in Stockholm, Sweden, is an international biopharmaceutical company. Sobi has a research focus on therapies in hematology, immunology, and more.Explore more
Sobi Org Chart
SB
Global Therapeutic Area Myeloid Neoplasms, Me...
SK
Clinical Development Hematology Head
SH
Head Director, Clinical Operationns Head of P...
Ed
Head Executive Director, Clinical Study Manag...
SR
Senior Director, Clinical Operations
JL
Director, Search and Evaluation
PK
Director, Patient Services
IO
Medical Director, Clinical Science
BD
Executive Medical Director, Medical Affairs
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sobi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sobi has new funding data
Check out if Sobi is spiking on competitors!
Click to see if Sobi had a recent Job posting/layoffs
Earning: See what the market has to say on Sobi recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Sobi
Sobi, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sobi has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sobi launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Sobi as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sobi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sobi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sobi.
Sobi financials insights
Gather financial insights about Sobi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Stock Offering
$65.4M
2016
Debt
$87.1M
Sobi Tech Stack
A closer look at the technologies used by Sobi
See more technologies
Most Recent Scoops
Hiring Plans
Sobi has more open roles in Medical & Health than it has had at any time in the past 12 months with an increased focus that include Hematology, and experience with Clinical Data Analysis, Medical Strategy, Life Sciences, Clinical Pharmacy, Medical Science Liaison, and Clinical Medicine.
Hiring Plans
Project
reported strong momentum for the US launch of Gamifant in macrophage activation syndrome (MAS), driven by increasing physician awareness and new patient demand, with international market growth also supported by the FDA label expansion. Sobi has completed regulatory filings in both Europe and Japan, with a regulatory decision expected in Japan in H2 2026.
Person-Based
Product Development
Earnings
reported that operating expenses for Q2 2026, excluding non-recurring items and amortization, increased by 24% at constant exchange rates compared to Q2 2025, with SG&A expenses increasing by 15% at constant exchange rates, driven by launch and pre-launch costs for Aspaveli in nephrology, NASP, and Tryngolza, partially offset by lower costs for VONJO and tofacitinib.
Earnings, Finance
Project
Pharmaceuticals, Clinical Operations
Sobi News & Media
Innate Pharma surges after a deal that secures its cash runway for another year
Innate Pharma shares are in strong demand this morning at the open, jumping 18.30% to 1.784, lifted by the announcement of a strategic $75m partnership with Swedish Orphan Biovitrum AB ....Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory...Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory...BioNTech taps Sobi executive Oelkers as its next CEO
Guido Oelkers will guide BioNTech’s ongoing transition into an oncology-focused biotech, while co-founder and longtime leader Ugur Sahin prepares to join a fledgling mRNA startup.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Sobi
Sign Up For FreeTo access detailed company insights
Sobi, founded in 2010 and based in Stockholm, Sweden, is an international biopharmaceutical company. Sobi has a research focus on therapies in hematology, immunology, and more.... Read More
